近年來臨床和流行病學研究發現，第二型糖尿病(T2DM)與阿茲海默症(AD)的發展有很高的相關性，有研究指出胰島素可參與AD相關蛋白如β-澱粉樣蛋白(Aβ)之調節。α-硫辛酸(ALA)已被證實可以改善糖尿病大鼠的胰島素阻抗。本研究探討ALA改善高脂飲食(HFD)及鏈脲佐菌素(STZ)誘導的糖尿病大鼠認知障礙、腦胰島素抵抗及突觸可塑性異常的效果。Wistar雄性大鼠給予HFD (60%脂肪卡路里) 4週後，以腹腔注射(ip) STZ (30mg/kg體重)誘發糖尿病。糖尿病大鼠每日管餵ALA 13週後，進行被動迴避試驗及Morris水迷宮試驗以評估大鼠認知功能。大鼠犧牲後採集血液及腦組織分析，並以Western blotting檢測海馬迴和皮質的胰島素訊息路徑、長期增益效應(LTP)及突觸可塑性相關蛋白的表現。被動迴避試驗與Morris水迷宮試驗結果顯示，給予ALA處理能顯著改善HFD/STZ誘導的糖尿病大鼠的認知功能障礙(p<0.05)。Western blotting分析結果顯示，給予ALA處理能顯著改善糖尿病大鼠海馬迴與皮質的突觸可塑性相關蛋白以及胰島素訊號傳導相關蛋白之表現(p<0.05)。在本研究結果發現，ALA可經由緩解糖尿病大鼠腦部胰島素阻抗來改善大腦神經突觸的可塑性及認知功能。目前ALA已是市面上的保健食品，希望可透過此研究讓ALA在未來也能作為阿茲海默症疾病的輔助用藥。

Recently, clinical and epidemiological studies suggest that T2DM is strongly interrelated with Alzheimer's disease (AD), and proposed that insulin involved in the modulation of AD-related proteins such as β-Amyloid (Aβ). Studies also reported that α-lipoic acid (ALA) improved insulin resistance in diabetic rats. This study examines the ameliorative effect of ALA on cognition impairment, cerebral insulin resistance and synaptic plasticity abnormality in high-fat diet (HFD) plus streptozotocin (STZ) induced diabetic rats. Male Wistar rats fed HFD (60% fat of calorie) for 4 weeks were intraperitoneally (ip) injected STZ (30mg/kg b.w.) to induce diabetes. The diabetic rats were orally administered with ALA once a day for 13 weeks. Passive avoidance test and Morris water maze test was performed to assess cognitive ability of rats. The blood and brain specimens were collected for biochemical analysis after the rats were sacrificed. Western blotting was used to determine the protein expressions of hippocampal and cortex insulin signaling pathway, long-term potentiation and synaptic plasticity-related proteins expression. The result from the passive avoidance test and Morris Water Maze test shows that the administration of ALA significantly improved the cognitive impairment in HFD/STZ-induced diabetic rats (p<0.05). Western blotting analysis indicates the expression of cerebral, including hippocampal and cortex, synaptic plasticity-related protein, and cerebral insulin signaling-related protein significantly increased in ALA-treated diabetic rats (p<0.05). The findings in this study suggest that ALA may ameliorate cognition impairment via improving cerebral synaptic plasticity and alleviating cerebral insulin resistance in diabetic rats.

Adeghate, E., Schattner, P., & Dunn, E. (2006). An update on the etiology and epidemiology of diabetes mellitus. Annals of the New York Academy of Sciences, 1084(1), 1-29.
Bedse, G., Di Domenico, F., Serviddio, G., & Cassano, T. (2015). Aberrant insulin signaling in Alzheimer's disease: current knowledge. Frontiers in neuroscience, 9, 204.
Biessels, G. J., Kamal, A., Urban, I. J., Spruijt, B. M., Erkelens, D. W., & Gispen, W. H. (1998). Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain research, 800(1), 125-135.
Bustamante, J., Lodge, J. K., Marcocci, L., Tritschler, H. J., Packer, L., & Rihn, B. H. (1998). α-Lipoic acid in liver metabolism and disease. Free Radical Biology and Medicine, 24(6), 1023-1039.
Chen, C. C., Shen, J. W., Chung, N. C., Min, M. Y., Cheng, S. J., & Liu, I. Y. (2012). Retrieval of context-associated memory is dependent on the CaV3. 2 T-type calcium channel. PLoS One, 7(1), e29384.
Chen, X., Nelson, C. D., Li, X., Winters, C. A., Azzam, R., Sousa, A. A., Leapman, R. D., Gainer, H., Sheng, M., & Reese, T. S. (2011). PSD-95 is required to sustain the molecular organization of the postsynaptic density. Journal of Neuroscience, 31(17), 6329-6338.
Cole, A. R., Astell, A., Green, C., & Sutherland, C. (2007). Molecular connexions between dementia and diabetes. Neuroscience & Biobehavioral Reviews, 31(7), 1046-1063.
Cordner, Z. A., & Tamashiro, K. L. (2015). Effects of high-fat diet exposure on learning & memory. Physiology & behavior, 152, 363-371.
Crump, F. T., Dillman, K. S., & Craig, A. M. (2001). cAMP-dependent protein kinase mediates activity-regulated synaptic targeting of NMDA receptors. Journal of Neuroscience, 21(14), 5079-5088.
de la Monte, S. M., & Wands, J. R. (2008). Alzheimer's disease is type 3 diabetes—evidence reviewed. Journal of diabetes science and technology, 2(6), 1101-1113.
Derakhshan, F., & Toth, C. (2013). Insulin and the brain. Current Diabetes Reviews, 9(2), 102-116.
Dey, A., Hao, S., Wosiski-Kuhn, M., & Stranahan, A. M. (2017). Glucocorticoid-mediated activation of GSK3β promotes tau phosphorylation and impairs memory in type 2 diabetes. Neurobiology of aging, 57, 75-83.
Eckel, R. H., Kahn, S. E., Ferrannini, E., Goldfine, A. B., Nathan, D. M., Schwartz, M. W., Smith, R. J., & Smith, S. R. (2011). Obesity and type 2 diabetes: what can be unified and what needs to be individualized?. The Journal of Clinical Endocrinology & Metabolism, 96(6), 1654-1663.
Evans, J. L., & Goldfine, I. D. (2000). α-Lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technology & Therapeutics, 2(3), 401-413.
Firouzjaei, M. A., Jafari, M. R., Eskandari, M., Anarkoli, I. J., & Alipour, M. (2014). Aminoguanidine changes hippocampal expression of apoptosis-related genes, improves passive avoidance learning and memory in streptozotocin-induced diabetic rats. Cellular and molecular neurobiology, 34(3), 343-350.
Frondoza, C. G., Fortuno, L. V., Grzanna, M. W., Ownby, S. L., Au, A. Y., & Rashmir-Raven, A. M. (2018). α-Lipoic Acid Potentiates the Anti-Inflammatory Activity of Avocado/Soybean Unsaponifiables in Chondrocyte Cultures. Cartilage, 9(3), 304-312.
Gu, C., Yang, X., & Huang, L. (2016). Cistanches Herba: A neuropharmacology review. Frontiers in Pharmacology, 7.
Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297(5580), 353-356.
Huerta, A. E., Prieto-Hontoria, P. L., Sáinz, N., Martínez, J. A., & Moreno-Aliaga, M. J. (2015). Supplementation with α-Lipoic Acid Alone or in Combination with Eicosapentaenoic Acid Modulates the Inflammatory Status of Healthy Overweight or Obese Women Consuming an Energy-Restricted Diet–4. The Journal of Nutrition, 146(4), 889S-896S.
Jolivalt, C. G., Lee, C. A., Beiswenger, K. K., Smith, J. L., Orlov, M., Torrance, M. A., & Masliah, E. (2008). Defective insulin signaling pathway and increased GSK-3 activity in the brain of diabetic mice: parallels with Alzheimer’s disease and correction by insulin. Journal of neuroscience research, 86(15), 3265.
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017). Is Alzheimer's disease a type 3 diabetes? A critical appraisal. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863(5), 1078-1089.
Kang, S., Kim, C. H., Jung, H., Kim, E., Song, H. T., & Lee, J. E. (2017). Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling. Neuropharmacology, 113, 467-479.
Kang, S., Lee, Y. H., & Lee, J. E. (2017). Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease. Yonsei Medical Journal, 58(3), 479-488.
Kazkayasi, I., Burul-Bozkurt, N., Merino-Serrais, P., Pekiner, C., Cedazo-Minguez, A., & Uma, S. (2018). Insulin deprivation decreases Insulin Degrading Enzyme levels in primary cultured cortical neurons and in the cerebral cortex of rats with streptozotocin-induced diabetes. Pharmacological Reports.
Lawton, M., Tong, M., Silbermann, E., Longato, L., Jiao, P., Mark, P., Wands, JR., & de la Monte, S. M. (2009). Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. Journal of Alzheimer's Disease, 16(4), 715-729.
Liu, Z., Patil, I., Sancheti, H., Yin, F., & Cadenas, E. (2017). Effects of Lipoic Acid on High-Fat Diet-Induced Alteration of Synaptic Plasticity and Brain Glucose Metabolism: A PET/CT and 13 C-NMR Study. Scientific reports, 7(1), 5391.
Maccioni, R. B., Farías, G., Morales, I., & Navarrete, L. (2010). The revitalized tau hypothesis on Alzheimer's disease. Archives of Medical Research, 41(3), 226-231.
Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S. O., Kanba, S., Kiyohara, Y., & Iwaki, T. (2010). Insulin resistance is associated with the pathology of Alzheimer disease The Hisayama Study. Neurology, 75(9), 764-770.
Miao, Y., He, T., Zhu, Y., Li, W., Wang, B., & Zhong, Y. (2015). Activation of hippocampal CREB by rolipram partially recovers balance between TNF-α and IL-10 levels and improves cognitive deficits in diabetic rats. Cellular and Molecular Neurobiology, 35(8), 1157-1164.
Midaoui, A. E., & de Champlain, J. (2002). Prevention of hypertension, insulin resistance, and oxidative stress by α-lipoic acid. Hypertension, 39(2), 303-307.
Mullard A (2017) BACE inhibitor bust in Alzheimer trial. Nat Rev Drug Discov 16:155.
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001). Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Progress in neurobiology, 63(1), 71-124.
Nicoll, R. A. (2017). A brief history of long-term potentiation. Neuron, 93(2), 281-290.
O'Brien, R. J., & Wong, P. C. (2011). Amyloid precursor protein processing and Alzheimer's disease. Annual review of neuroscience, 34, 185-204.
Olefsky, J. M., & Glass, C. K. (2010). Macrophages, inflammation, and insulin resistance. Annual review of physiology, 72, 219-246.
Ott, A., Stolk, R. P., Van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999). Diabetes mellitus and the risk of dementia The Rotterdam Study. Neurology, 53(9), 1937-1937.
Packer, L., Witt, E. H., & Tritschler, H. J. (1995). Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine, 19(2), 227-250.
Pozueta, J., Lefort, R., & Shelanski, M. L. (2013). Synaptic changes in Alzheimer’s disease and its models. Neuroscience, 251, 51-65.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013). The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's & Dementia, 9(1), 63-75.
Qiu, W. Q., & Folstein, M. F. (2006). Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis. Neurobiology of Aging, 27(2), 190-198.
Reed, L. J. (2001). A trail of research from lipoic acid to α-keto acid dehydrogenase complexes. Journal of Biological Chemistry, 276(42), 38329-38336.
Reitz, C., Brayne, C., & Mayeux, R. (2011). Epidemiology of Alzheimer disease. Nature Reviews Neurology, 7(3), 137-152.
Robert, V. (2004). BACE1: The beta-Secretase Enzyme in Alzheimer's Disease. Journal of Molecular Neuroscience, 23(1-2), 1-2.
Rodriguez-Perdigon, M., Solas, M., Moreno-Aliaga, M. J., & Ramirez, M. J. (2016). Lipoic acid improves neuronal insulin signalling and rescues cognitive function regulating VGlut1 expression in high-fat-fed rats: Implications for Alzheimer's disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1862(4), 511-517.
Rossetti, T., Banerjee, S., Kim, C., Leubner, M., Lamar, C., Gupta, P., Lee, B., Neve, R., & Lisman, J. (2017). Memory erasure experiments indicate a critical role of CaMKII in memory storage. Neuron, 96(1), 207-216.
Selkoe, D. J., & Hardy, J. (2016). The amyloid hypothesis of Alzheimer9s disease at 25 years. EMBO Molecular Medicine, 8(6), 595-608.
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009). Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta (BBA)-General Subjects, 1790(10), 1149-1160.
Siegelbaum, S. A., & Hudspeth, A. J. (2000). Principles of neural science (Vol. 4, pp. 1227-1246). E. R. Kandel, J. H. Schwartz, & T. M. Jessell (Eds.). New York: McGraw-hill.
Silva, A. J., Kogan, J. H., Frankland, P. W., & Kida, S. (1998). CREB and memory. Annual review of neuroscience, 21(1), 127-148.
Špolcová, A., Mikulášková, B., Kršková, K., Gajdošechová, L., Zórad, Š., Olszanecki, R., Suski M., Bujak-Giżycka B, Železná B & Maletínská, L. (2014). Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity-and age-induced peripheral insulin resistance: a study in Zucker rats. BMC Neuroscience, 15(1), 111.
Tabrizian, K., Yaghoobi, N. S., Iranshahi, M., Shahraki, J., Rezaee, R., & Hashemzaei, M. (2015). Auraptene consolidates memory, reverses scopolamine-disrupted memory in passive avoidance task, and ameliorates retention deficits in mice. Iranian journal of basic medical sciences, 18(10), 1014.
Vorhees, C. V., & Williams, M. T. (2006). Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature protocols, 1(2), 848.
Wang, N., Chen, L., Cheng, N., Zhang, J., Tian, T., & Lu, W. (2014). Active calcium/calmodulin-dependent protein kinase II (CaMKII) regulates NMDA receptor mediated postischemic long-term potentiation (i-LTP) by promoting the interaction between CaMKII and NMDA receptors in ischemia. Neural plasticity, 2014.
Wang, S., Yang, H., Yu, L., Jin, J., Qian, L., Zhao, H., Xu, Y., & Zhu, X. (2014). Oridonin attenuates Aβ1–42-induced neuroinflammation and inhibits NF-κB pathway. PloS one, 9(8), e104745.
Weinstein, G., R Preis, S., S Beiser, A., Kaess, B., C Chen, T., Satizabal, C., Rahman, F., J Benjamin, E., S Vasan, R., & Seshadri, S. (2017). Clinical and environmental correlates of serum BDNF: a descriptive study with plausible implications for AD research. Current Alzheimer Research, 14(7), 722-730.
Yang, Y., Li, W., Liu, Y., Li, Y., Gao, L., & Zhao, J. J. (2014). Alpha-lipoic acid attenuates insulin resistance and improves glucose metabolism in high fat diet-fed mice. Acta Pharmacologica Sinica, 35(10), 1285.
Zhang, Y. H., Wang, D. W., Xu, S. F., Zhang, S., Fan, Y. G., Yang, Y. Y., Guo, S. Q., Wang, S., Guo, T., Wang, Z. Y., & Guo, C. (2018). α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice. Redox Biology, 14, 535-548.
吳佩芩(2017)。咖啡胺衍生物K36緩解高脂飲食及STZ誘發第二型糖尿病大鼠認知功能損傷之探討。國立臺灣師範大學碩士論文。
社團法人中華民國糖尿病學會(2015)。2015糖尿病臨床照護指引。台北市。
邱銘章、王培寧、孫瑜、傅中玲、陳達夫、林克能、花茂棽（2013）。失智症 (含輕度認知功能障礙 mild cognitive impairment, MCI) 流行病學調查及失智症照護研究計畫。衛生福利部科技研究計劃成果報告（編號：DOH102-TD-M-113-100001）。臺北:台灣失智症協會。
涂孟萱(2017)。硫辛酸抑制NLRP3發炎體活化而減緩高脂飲食及STZ誘發第二型糖尿病大鼠內臟脂肪組織發炎反應之研究。國立臺灣師範大學碩士論文。
張采文(2011)。植多酚作用於小鼠C2C12骨骼肌細胞中抑制由游離脂肪酸所引起之胰島素抗性機制探討。臺灣大學生物化學暨分子生物學研究所學位論文 。
張俊芳, 楊東, & 祁金順. (2010). β-澱粉樣蛋白對海馬長時程增強的影響. 生理學報, (6), 479-488.